Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Christopher Richard Anzalone Insider Profile
4 Followers
Christopher Richard Anzalone, CEO, Director at Arrowhead Pharmaceuticals, holds 3.72M shares in Arrowhead Pharmaceuticals (Ticker: ARWR).
Christopher Richard Anzalone Arrowhead Pharmaceuticals (ARWR)CEO, Director
Arrowhead Pharmaceuticals (ARWR)
CEO, Director
Ranked #86,432 out of 99,335 Corporate Insiders
Profitable Transactions
1 out of 6 Profitable Transactions
Average Return
-28.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Christopher Richard Anzalone's holdings
Insider Roles
CEO, Director
Roles that Christopher Richard Anzalone holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:May 05, 2023 - May 05, 2024
Return:+40.90%
The most profitable trade made by Christopher Richard Anzalone
Christopher Richard Anzalone's Trading History
List of latest transactions for each holding click on a transaction to see Christopher Richard Anzalone's performance on stock
You May Also Like
Christopher Richard Anzalone insider profile FAQ
What is the percentage of profitable transactions made by Christopher Richard Anzalone?
The percentage of profitable transactions made by Christopher Richard Anzalone is 17%.
What is the average return per transaction made by Christopher Richard Anzalone?
The average return per transaction made by Christopher Richard Anzalone is -28.30%.
What stocks does Christopher Richard Anzalone hold?
Christopher Richard Anzalone holds: ARWR stocks.
What was Christopher Richard Anzalone’s latest transaction?
Christopher Richard Anzalone latest transaction was an Uninformative Buy of $836.04K.
What was Christopher Richard Anzalone's most profitable transaction?
Christopher Richard Anzalone’s most profitable transaction was an Informative Sell of ARWR stock on May 5, 2023. The return on the trade was 40.90%.
What is Christopher Richard Anzalone's role in Arrowhead Pharmaceuticals?
Christopher Richard Anzalone's role in Arrowhead Pharmaceuticals is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.